Feed aggregator

FDA Sends Warning to CBD Companies

The Joint Blog - Wed, 11/01/2017 - 22:11
The Food and Drug Administration (FDA) has sent warning letters to multiple companies involved in the distribution of products containing cannabidiol (CBD).

fdaThe FDA sent warning letters today to four CBD-related companies claiming them to be making unsubstantiated claims “related to more than 25 different products spanning multiple product webpages, online stores and social media websites”. The companies are Natural Alchemist (California), Greenroads Health (Florida), That’s Natural! Marketing & Consulting (Colorado), and Stanley Brothers Social Enterprises LLC (also Colorado).

“As part of the U.S. Food and Drug Administration’s ongoing efforts to protect consumers from health fraud, the agency today issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these outcomes”, states a Wednesday press release. “Selling these unapproved products with unsubstantiated therapeutic claims is not only a violation of the Federal Food, Drug and Cosmetic Act, but also can put patients at risk as these products have not been proven to be safe or effective. The deceptive marketing of unproven treatments may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”

The release states that the FDA “has grown increasingly concerned at the proliferation of products claiming to treat or cure serious diseases like cancer. In this case, the illegally sold products allegedly contain cannabidiol (CBD), a component of the marijuana plant that is not FDA approved in any drug product for any indication.” The companies receiving warning letters “distributed the products with unsubstantiated claims regarding preventing, reversing or curing cancer; killing/inhibiting cancer cells or tumors; or other similar anti-cancer claims. Some of the products were also marketed as an alternative or additional treatment for Alzheimer’s and other serious diseases.”

“Substances that contain components of marijuana will be treated like any other products that make unproven claims to shrink cancer tumors”, said FDA Commissioner Scott Gottlieb “We don’t let companies market products that deliberately prey on sick people with baseless claims that their substance can shrink or cure cancer and we’re not going to look the other way on enforcing these principles when it comes to marijuana-containing products.”

According to The Cannabist, the FDA issued similar warning letters to CBD product makers in 2015 and 2016.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post FDA Sends Warning to CBD Companies appeared first on TheJointBlog.

Trump’s Commission Denies Evidence That Cannabis Can Mitigate Opioid Abuse

NORML Blog - Wed, 11/01/2017 - 19:37

Despite the growing body of scientific evidence showing that cannabis access is associated with reductions in opioid use and mortality, the Chairman of the White House’s Commission on Combating Drug Addiction and the Opioid Crisis today called upon the President to reject any efforts to acknowledge marijuana’s promising role in mitigating opioid abuse and dependency.

In a letter sent today to President Donald Trump by New Jersey Gov. Chris Christie, Chairman of the Committee, he writes:

“The Commission acknowledges that there is an active movement to promote the use of
marijuana as an alternative medication for chronic pain and as a treatment for opioid addiction. … There is a lack of sophisticated outcome data on dose, potency, and abuse potential for marijuana. This mirrors the lack of data in the 1990’s and early 2000’s when opioid prescribing multiplied across health care settings and led to the current
epidemic of abuse, misuse and addiction. The Commission urges that the same mistake is not made with the uninformed rush to put another drug legally on the market in the midst of an overdose epidemic.”

President Trump established the Commission in May via an executive order. Members of the Commission issued their policy recommendations today.

In recent months, dozens of peer-reviewed studies have concluded that legal cannabis access is associated with reduced rates of opioid use, spending, abuse, hospitalization, and mortality. Summaries and links to these studies are available here.

Despite over 10,000 advocates communicating this information to the Commission, members of the committee have chosen to disregard it. Moreover, Gov. Christie opines in today’s letter that cannabis exposure increases the likelihood that one will become opioid dependent — an allegation that was recently rejected by the National Academy of Sciences, which, in a January 2017 review of some 10,000 peer-reviewed studies, failed to identify even one “good or fair-quality systematic review that reported on the association between cannabis use and the initiation of use of opioids.”

NORML thanks the thousands of you who took the time to try to inform and educate this Commission and regrets that its members continue to place political ideology above the health and safety of American lives.

FDA sends warning letters to CBD companies, including Colorado's CW Hemp

Cannabist - Wed, 11/01/2017 - 17:40
Four firms that make CBD products, including CW Hemp, known for "Charlotte's Web," were warned by the FDA for illegally making unsubstantiated health claims.

Delaware cannabis legalization panel issues warnings to state, including one about Sessions

Cannabist - Wed, 11/01/2017 - 16:04
State finance officials are advising caution as lawmakers consider legalizing recreational marijuana use in Delaware.

Domestic Hemp Production More Than Doubles In Past Year

NORML Blog - Tue, 10/31/2017 - 20:40

Domestic hemp production increased dramatically from 2016 to 2017, according to data compiled by the advocacy organization Vote Hemp.

The group calculates that US farmers cultivated over 23,000 acres of hemp in 2017, up from fewer than 10,000 acres in 2016.

Under a 2014 federal law, states may license hemp cultivation as part of a university sponsored pilot program. Thirty-two universities in nineteen states – including Colorado, Kentucky, Minnesota, New York, North Dakota, Oregon, and Tennessee – have participated in hemp cultivation projects this year.

“The majority of states have implemented hemp farming laws, in clear support of this crop and its role in diversifying and making more sustainable our agricultural economy,” Vote Hemp President Eric Steenstra said in a prepared statement. “It’s imperative that we pass the Industrial Hemp Farming Act in Congress, so that we can grant farmers full federally legal rights to commercially cultivate hemp to supply the growing global market for hemp products.”

House Bill 3530: The Industrial Hemp Farming Act of 2017 excludes cannabis strains under 0.3 percent THC from the federal definition of marijuana under the Controlled Substances Act. The bill is assigned before the House Judiciary Committee, Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Here is the First Fortune 500 Marijuana Stock

The Joint Blog - Tue, 10/31/2017 - 18:43

By Charles Bovaird, Investopedia.com

Constellation Brands, Inc. (STZ)—a Fortune 500 company that owns brands such as Corona beer, Black Velvet Whisky and Casa Noble tequila—recently agreed to take a 9.9% stake in Canadian marijuana company Canopy Growth Corp. (TWMJF). The two companies plan to work together to develop and market beverages that will be infused with Cannabis, according to The Wall Street Journal. (For more, see also: Top 4 Marijuana Stocks to Watch.)

Legalization Spreads

Rob Sands, president and CEO of Constellation Brands, told The Journal that the U.S. government will probably legalize marijuana at the federal level in the coming years, considering “what’s happened at the state level.” Even if these expectations don’t materialize, his company could sell marijuana-infused beverages in Canada, where they are expected to be legalized by 2019.

Since Canopy Growth is the world’s largest publicly traded marijuana company, the decision made by Constellation Brands gives the beverage maker a strong presence in the marijuana industry, The Journal reported.

Shifting Demographics

Constellation Brands made this move at a time when there is evidence that some consumers are reducing their alcohol consumption in favor of marijuana, according to Fortune.

“We believe alcohol could be under pressure for the next decade,” analysts for Cowen Inc. (COWN), led by Viven Azer, wrote in a note earlier this year, Fortune reported. “Consumer survey work suggests [about] 80% of consumers reduce their alcohol consumption with cannabis in the mix.”

Currently, 28 states and the District of Columbia have legalized marijuana in one capacity or another, according to The Journal. Should more states permit the use of this drug, consumption could rise sharply, providing a strong market for edibles that are infused with marijuana. (For more, see also: Which States Have Legal Pot & Will It Stay Legal?)

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Here is the First Fortune 500 Marijuana Stock appeared first on TheJointBlog.

Virginia Senate Majority Leader Working on Bill to Decriminalize Marijuana

The Joint Blog - Tue, 10/31/2017 - 18:38
One of Virginia’s top lawmakers is currently working on legislation that would decriminalize marijuana throughout the state.

Senate Majority Leader Tommy Norment, a Republican, says he’s in the process of drafting a bill that would remove the possibility of jail time for those caught possessing marijuana. The measure is likely to effect those caught possessing an ounce or less. Under current Virginia law, those caught possessing up to half an ounce of marijuana can be charged with a misdemeanor and imprisoned for up to 30 days; for subsequent offenses the potential jail time rises to a year. Possessing over half an ounce is a felony punishable by 1 to 10 years in prison.

Norment’s announcement that he’s working on a decriminalization measure comes shortly after the release of a State Crime Commission study which found that such a law would prevent over 10,000 arrests every year in Virginia. Not only would this save taxpayer money to persecute and imprison marijuana users, it will prevent the life-altering consequences associated with a marijuana misdemeanor.

According to the commission’s study, Virginia police have arrested more than 133,000 people on first-time marijuana offenses in the last decade alone.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Virginia Senate Majority Leader Working on Bill to Decriminalize Marijuana appeared first on TheJointBlog.

Virginia State Crime Commission Holds Hearing On Decriminalization

NORML Blog - Tue, 10/31/2017 - 17:55

On Monday, October 30th, I took a short trip down to Richmond, Virginia to testify alongside Virginia NORML regarding proposals to decriminalize the personal possession of marijuana, in order for those who are stopped by law enforcement to no longer face jail time or a criminal charge.

Among the policy proposals are options that are line with those of numerous other states, including Nebraska and Mississippi. Such a change will save taxpayers money and allow police and the courts to re-prioritize their resources toward addressing more serious crimes.

Minor marijuana possession offenders, many of them young people, should not be saddled with a criminal record and the lifelong penalties and stigma associated with it.

Watch the testimony of Jenn Michelle Pedini, Executive Director of Virginia NORML below. You can support their work by clicking here. 

Why marijuana should be legal infographic

The Leaf Online - Tue, 10/31/2017 - 14:52

Cannabis is our nation’s number one cash crop and now 64% of the population, including a majority of Republicans, believe it should be legalized. Trump said he would legalize medical marijuana and leave it up to the states to decide. And yet progress remains stalled in the GOP dominated Congress, where House Republicans recently launched […]

The post Why marijuana should be legal infographic appeared first on The Leaf Online.

Congressional Lawmakers Demand The VA Study Medical Marijuana

NORML Blog - Mon, 10/30/2017 - 21:44

Members of the US House Committee on Veteran’s Affairs are demanding the Department of Veterans Affairs facilitate protocols to assess the efficacy of medical cannabis in veterans suffering from chronic pain and post-traumatic stress.

Minnesota Democrat Tim Walz, along with nine other Democrat members of the Committee, authored an October 26, 2017 letter to VA Secretary David Shulkin stating: “[The] VA is uniquely situated to pursue research on the impact of medical marijuana on veterans suffering from chronic pain and PTSD given its access to world class researchers, the population it serves, and its history of overseeing and producing research resulting in cutting-edge medical treatments. … VA’s pursuit of research into the impact of medical marijuana on the treatment of veterans diagnosed with PTSD who are also experiencing chronic pain is integral to the advancement of health care for veterans and the nation. We ask VA to respond … with a commitment to the development of VHA-led research into this issue.”

In September, representatives from The American Legion addressed a separate letter to VA Secretary Shulkin encouraging the VA assist in an ongoing, FDA-approved clinical trial assessing the safety and efficacy of various strains of cannabis in veterans with PTSD. To date, the VA has refused to assist in patient recruitment for the trial. The VA has yet to publicly respond to the Legion’s letter.

Survey data finds that military veterans report using cannabis therapeutically at rates far higher than the do those in the general population, and that many are already using it as an alternative to conventional medications in the treatment of pain and post-traumatic stress.

Oaksterdam U sets 10th anniversary fete

The Leaf Online - Mon, 10/30/2017 - 14:33

Ten years ago, the world’s first cannabis college featuring a multicourse curriculum, examinations and a graduation certificate opened its doors on 15th Street in Downtown Oakland with a small paper sign posted in its doorway. Now the world famous Oaksterdam University, OU, will host its Tenth Anniversary fete on November 18, and tickets are still […]

The post Oaksterdam U sets 10th anniversary fete appeared first on The Leaf Online.

There’s Now More Marijuana Shops in Colorado than Starbucks or McDonalds

The Joint Blog - Mon, 10/30/2017 - 05:32
There are now more marijuana stores in Colorado than Starbucks or Mcdonalds.

There are nearly 500 stores in Colorado that are licensed to legally distribute cannabis and cannabis products to anyone 21 and older, according to figures released by the state. This is considerably more than the number of Starbucks in the state (392), and well over twice the number of McDonalds (208). Clearly, times are changing.

The large number of marijuana stores have results in over $1 billion in legal marijuana being sold in the first 8 months of the year. These sales have resuled in over $162 million in taxes for the state.

Since legal marijuana sales began in Colorado in 2014, there’s been roughly $4 billion in marijuana sold: $699 million in 2014, $996 million in 2015, $1.3 billion in 2016, and $1.02 billion so far this year.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post There’s Now More Marijuana Shops in Colorado than Starbucks or McDonalds appeared first on TheJointBlog.

New Jersey Officials Approve Adding Five New Medical Cannabis Conditions

The Joint Blog - Mon, 10/30/2017 - 03:46
New Jersey officials have given approval to the addition of five new medical conditions to the state’s medical cannabis program.

New Jersey’s Medicinal Marijuana Review Panel voted this week to allow the medical use of cannabis for those with migraines, anxiety, Tourette’s syndrome, chronic pain related to musculoskeletal disorders, and chronic pain related to internal organs.

Although the panel was in strong support of allowing individuals with these conditions to become legal medical cannabis patients, State Health Commissioner Cathleen D. Bennett has the final say. She now has up to 180 days to respond; she has the option of approving all five conditions, approving some of the five, or not approving any of them.

If Commissioner Bennett does approve the new conditions, it would help to expand one of the nation’s more restrictive medical cannabis programs. Currently there are around 12,500 registered patients, and only five currently operating dispensaries.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post New Jersey Officials Approve Adding Five New Medical Cannabis Conditions appeared first on TheJointBlog.

Using cannabis in place of anxiety meds

The Leaf Online - Sun, 10/29/2017 - 11:20

Everyone feels anxious at one point or another, but this anxiety becomes debilitating when its associated symptoms start to impede a person’s ability to function normally every day. General anxiety disorder (GAD) is often characterized by excessive worry. The worry may be with or without any actual basis, and someone suffering from GAD will struggle […]

The post Using cannabis in place of anxiety meds appeared first on The Leaf Online.

Stanford Study: Marijuana Use Linked to More Sex

The Joint Blog - Sat, 10/28/2017 - 22:02
A study conducted by researchers at Stanford University School of Medicine has found that “despite concerns among physicians and scientists that frequent marijuana use may impair sexual desire or performance, the opposite appears more likely to be the case.”

(Photo: THC Finder).

The study, published online Oct. 27 in the Journal of Sexual Medicine, are based on an analysis of more than 50,000 Americans ages 25-45. Researchers call the results “unambiguous”.

“Frequent marijuana use doesn’t seem to impair sexual motivation or performance. If anything, it’s associated with increased coital frequency,” said the study’s senior author, Michael Eisenberg, MD, assistant professor of urology. The lead author is Andrew Sun, MD, a resident in urology.

The study does not establish a causal connection between marijuana use and sexual activity, Eisenberg noted. But the results hint at it, he added. “The overall trend we saw applied to people of both sexes and all races, ages, education levels, income groups and religions, every health status, whether they were married or single and whether or not they had kids.” According to Eisenber, the study is the first to examine the relationship between marijuana use and frequency of sexual intercourse at the population level in the United States.

“Marijuana use is very common, but its large-scale use and association with sexual frequency hasn’t been studied much in a scientific way,” Eisenberg said.

To arrive at an accurate determination of marijuana’s effect on intercourse frequency, Eisenberg and Sun turned to the National Survey of Family Growth, sponsored by the federal Centers for Disease Control and Prevention. The survey, which provides data pertaining to family structures, sexual practices and childbearing, reflects the overall demographic features of the U.S. population. Originally conducted at regular intervals, the survey is now carried out on an annual basis. It explicitly queries respondents on how many times they’ve had intercourse with a member of the opposite sex in the past four weeks, and how frequently they’ve smoked marijuana over the past 12 months.

The investigators compiled answers to those questions for all years since 2002, when the survey first began collecting data on men as well as women. They included data from respondents ages 25-45 and excluded a small percentage (fewer than 3 percent) of respondents who had failed to answer one or more relevant questions.

In all, Eisenberg and Sun obtained data on 28,176 women averaging 29.9 years of age and 22,943 men whose average age was 29.5. They assessed these individuals’ self-reported patterns of marijuana use over the previous year and their self-reported frequency of heterosexual intercourse over the previous four weeks.

Some 24.5 percent of men and 14.5 percent of women in the analysis reported having used marijuana, and there was a positive association between the frequency of marijuana use and the frequency of sexual intercourse. This relationship applied to both sexes: Women denying marijuana use in the past year, for example, had sex on average 6.0 times during the previous four weeks, whereas that number was 7.1 for daily pot users. Among men, the corresponding figure was 5.6 for nonusers and 6.9 for daily users.

In other words, pot users are having about 20 percent more sex than pot abstainers, Eisenberg noted.

Positive association is universal

Moreover, Eisenberg said, the positive association between marijuana use and coital frequency was independent of demographic, health, marital or parental status.

In addition, the trend remained even after accounting for subjects’ use of other drugs, such as cocaine or alcohol. This, Eisenberg said, suggests that marijuana’s positive correlation with sexual activity doesn’t merely reflect some general tendency of less-inhibited types, who may be more inclined to use drugs, to also be more likely to have sex. In addition, coital frequency rose steadily with increasing marijuana use, a dose-dependent relationship supporting a possible active role for marijuana in fostering sexual activity.

Nevertheless, Eisenberg cautioned, the study shouldn’t be misinterpreted as having proven a causal link. “It doesn’t say if you smoke more marijuana, you’ll have more sex,” he said.

Stanford’s Department of Urology supported the work.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Stanford Study: Marijuana Use Linked to More Sex appeared first on TheJointBlog.

Cannabis Opponents Take Halloween Cannabis Candy Scare Tactics To New States

Weed News - Sat, 10/28/2017 - 18:39
Cannabis opponents are some of the most desperate members of the public policy world. While I can’t understand why opponents continue to push reefer madness, I can understand why they are so...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

CN AB: Column: Despite Fanfare, Medical Benefits Of Marijuana Remain

MAP - Cannabis - Sat, 10/28/2017 - 07:00
Medicine Hat News, 28 Oct 2017 - Many Canadians can hardly wait for the day that the recreational use of marijuanabecomes legal. As a medical doctor, I'm far less enthusiastic. I worry about two things: The experimental nature of marijuana in medical practice and the public health consequences of legalized marijuana. Before you write me off as overly prudish or an anti-marijuana conservative, let me say out of the gate that I'm not opposed to legalized marijuana in principle - I'm just paying attention to the evidence, or rather, the lack of it. My concern is that as marijuanabecomes more easily available, Canadians may become more inclined to self-medicate with this so-called "miracle drug."

CN AB: Former Cop Urges Caution Regarding Cannabis In The Workplace

MAP - Cannabis - Sat, 10/28/2017 - 07:00
Medicine Hat News, 28 Oct 2017 - Ed Secondiak began his Friday lecture on cannabis in the workplace by cautioning against potential dangers of the soon-to-be-legalized substance. "We would consider marijuana a dangerous drug simply because impairment is not recognized by the individual or perhaps the person (working) with them," said Secondiak, a former drug enforcement RCMP officer who now works with ECS Safety.

S03E28: She lobbies for policy change and education about hemp and marijuana

Cannabist - Fri, 10/27/2017 - 22:00
Featured guest: Samantha Walsh, CEO and co-founder of Tetra Public Affairs, a cannabis consulting firm. Talking about hemp education, CBD and marijuana industry matters.

Cannabist Show: She lobbies for policy change and education on hemp and marijuana

Cannabist - Fri, 10/27/2017 - 21:47
Featured guest: Samantha Walsh, CEO and co-founder of Tetra Public Affairs, a cannabis consulting firm. Talking about hemp education, CBD and marijuana industry matters.
Syndicate content